• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BELLUS Health Inc

+ Add to Watchlist

BLUSF:US

1.1300 USD 0.0173 1.51%

As of 09:30:01 ET on 08/22/2014.

Snapshot for BELLUS Health Inc (BLUSF)

Open: 1.1300 Day's Range: 1.1300 - 1.1300 Volume: 116
Previous Close: 1.1473 52wk Range: 0.3320 - 1.2100 1-Yr Rtn: +240.68%

Stock Chart for BLUSF

No chart data available.
  • BLUSF:US 1.1300
  • 1D
  • 1M
  • 1Y
1.1473
Interactive BLUSF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLUSF

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2013) -
Est. PEG Ratio -
Market Cap (M USD) 54.41
Shares Outstanding (M) 47.43
30 Day Average Volume 6,317
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLUSF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for BLUSF

BELLUS Health Inc. develops and commercializes therapeutics for neurological disorders. The Company has products in clinical trials for AA amyloidosis, the treatment of Alzheimer's Disease, and for the prevention of hemorrhagic stroke caused by amyloid angiopathy.

Roberto BelliniPresident/CEODenis GarceauSenior VP:Drug Development
Francois DesjardinsVP:FinanceTony MatzouranisVP:Business Development
More Company Profile & Key Executives for BLUSF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil